Two newer epilepsy drugs may not harm the thinking skills or IQs of school-aged children whose mothers took them while pregnant - but an older drug is linked to cognitive problems in children, especially if their mothers took high doses - according to new research from The University of Manchester.
Valproate, one of the most commonly prescribed antiepileptic medications, has been associated in the past with birth defects and developmental problems. However, two newer drugs - levetiracetam and topirimate - have had little or no investigations into their developmental impact until this latest research, published published in the August 31, 2016, issue of Neurology®, the medical journal of the American Academy of Neurology.